Yamazaki, Naoya
National Cancer Center Hospital
4 papers on CoChatORCID 0000-0002-9638-0428
Most cited papers
- Verified
Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma
Weber, J., Mandala, M., Del Vecchio, M., Gogas, H. J., Arance, A. M., Cowey, C. L., Dalle, S., Schenker, M., Chiarion-Sileni, V., Marquez-Rodas, I., et al. (2017) · New England Journal of Medicine
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 2,246
- Verified
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
Kumagai, S., Koyama, S., Itahashi, K., Tanegashima, T., Lin, Y.-T., Togashi, Y., Kamada, T., Irie, T., Okumura, G., Kono, H., et al. (2022) · Cancer Cell
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 892
- Verified
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
Sawada, Y., Yoshikawa, T., Ofuji, K., Yoshimura, M., Tsuchiya, N., Takahashi, M., Nobuoka, D., Gotohda, N., Takahashi, S., Kato, Y., et al. (2016) · OncoImmunology
Hepatocellular Carcinoma Treatment and PrognosisImmunotherapy and Immune Responses
Cited by 178
- Verified
Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab
Kimbara, S., Fujiwara, Y., Iwama, S., Ohashi, K., Kuchiba, A., Arima, H., Yamazaki, N., Kitano, S., Yamamoto, N., & Ohe, Y. (2018) · Cancer Science
Thyroid Disorders and TreatmentsCancer Immunotherapy and Biomarkers
Cited by 158
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free